Patients diagnosed with diabetes are initiating GLP-1 treatment more quickly than ever before Since 2021, the average time between a diabetes diagnosis and the initiation of a GLP-1 therapy has decreased by about one month, underscoring how quickly these drugs have moved to the forefront of care
There are chances of improvement by enriching brain GSH levels in MCI patients
Rash and skin irritation are uncommon but documented reactions in people taking semaglutide-based medications like Ozempic
Masoodi M, Gastaldelli A, Hytylinen T, Arretxe E, Alonso C, Gaggini M
Mounjaro (tirzepatide) A once-weekly dual GLP-1/GIP receptor agonist
Allulose is a low-calorie sweetener naturally found in small amounts in wheat, fruits like raisins, kiwis, and figs, as well as molasses, brown sugar, and maple syrup